AMRN Q1 2022 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$310M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$95M-33.4% YoY

Gross Profit

$72M76.5% margin

Operating Income

-$28M-29.9% margin

Net Income

-$32M-33.4% margin

EPS (Diluted)

$-1.59

QoQ Revenue Growth

-34.5%

Cash Flow

Operating Cash Flow

-$98M

Free Cash Flow

-$98M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$974M

Total Liabilities

$333M

Stockholders' Equity

$641M

Cash & Equivalents

$219M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$95M	$142M	-33.4%
Gross Profit	$72M	$114M	-36.4%
Operating Income	-$28M	-$1M	-2026.7%
Net Income	-$32M	-$2M	-1841.1%

Revenue Segments

Product

$94M99%

Licensing And Royalty

$644,0001%